Stay updated on Pepinemab for Pediatric Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Pepinemab for Pediatric Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pepinemab for Pediatric Solid Tumors Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    7 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in the phase I/II trial studying the side effects and best dose of pepinemab in treating younger patients with solid tumors that have come back after treatment or do not respond to treatment.
    Difference
    0.1%
    Check dated 2024-06-06T14:26:38.000Z thumbnail image
  7. Check
    22 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to provide a detailed explanation of eligibility criteria for clinical research, including examples such as a person's general health condition or prior treatments. The new description also directs users to 'Learn About Studies' for more general information about clinical research.
    Difference
    44%
    Check dated 2024-05-22T20:54:29.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:40:17.000Z thumbnail image

Stay in the know with updates to Pepinemab for Pediatric Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pepinemab for Pediatric Solid Tumors Clinical Trial page.